Evidence map›Paper›PMID 39858098›Full record

ReviewCancers2025

Urogenital Cancer Epidemiology in Poland (1980-2020): A Narrative Review.

Iwona Wnętrzak, Joanna Didkowska, Roman Sosnowski, Mateusz Czajkowski, Dawid Sigorski, Bartosz Małkiewicz, Piotr Marczyński, Jarosław Jaskulski, Piotr Kania, Adam Ostrowski and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Iwona WnętrzakDepartment of General and Oncological Urology, Praski Hospital, 03-401 Warsaw, Poland.ORCID 0009-0009-2567-1904
Joanna DidkowskaDepartment of Epidemiology and Cancer Prevention, Polish National Cancer Registry, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Roman SosnowskiDepartment of Urology and Oncological Urology, MSWiA Hospital, Warmian-Masurian Cancer Center, 10-228 Olsztyn, Poland.ORCID 0000-0002-4894-4233
Mateusz CzajkowskiDepartment of Urology, Medical University of Gdańsk, Mariana Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.ORCID 0000-0003-2017-5417
Dawid SigorskiDepartment of Oncology, University of Warmia and Mazury in Olsztyn, 10-228 Olsztyn, Poland.ORCID 0000-0002-4799-9611
Bartosz MałkiewiczDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-367 Wrocław, Poland.ORCID 0000-0002-5933-3753
Piotr MarczyńskiDepartment of General and Oncological Urology, Praski Hospital, 03-401 Warsaw, Poland.
Jarosław JaskulskiDepartment of Urology, Holycross Cancer Center, 25-734 Kielce, Poland.
Piotr KaniaDepartment of Urology and Oncological Urology, St. John Paul II Mazovian Regional Hospital in Siedlce, 08-110 Siedlce, Poland.
Adam OstrowskiDepartment of Urology and Andrology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-067 Bydgoszcz, Poland.ORCID 0000-0002-5057-3507
Artur SieczychDepartment of General and Oncological Urology, Praski Hospital, 03-401 Warsaw, Poland.
Grzegorz KadeMilitary Institute of Aviation Medicine, 01-755 Warsaw, Poland.
Piotr PurpurowiczThe Municipal Polyclinical Hospital in Olsztyn, 10-045 Olsztyn, Poland.
Stanisław SzemplińskiSecond Department of Urology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland.
Robert NowakowskiDepartment of Urology and Oncological Urology, MSWiA Hospital, Warmian-Masurian Cancer Center, 10-228 Olsztyn, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite advances in prophylaxis, early diagnosis, and treatment, urogenital cancers represent a significant challenge to public health in Poland due to their relatively high prevalence and mortality rates. This narrative review aims to explore contemporary evidence on the epidemiology of urogenital cancers in Poland, such as prostate cancer, bladder cancer, kidney cancer, testicular cancer, and penile cancer, focusing on current and historical status and trends in the broader context of healthcare delivery. The literature consistently indicates that urogenital cancer continues to be a significant contributor to cancer incidence and mortality rates in Poland. Although the body of evidence is expanding, its quantity remains limited, primarily attributable to the scarcity of top-notch epidemiological investigations targeting particular forms of cancer, such as testicular and penile cancers, which are characterized by sporadic occurrences.

Indexed as

bladder cancerepidemiologykidney cancerpenile cancerprostate cancertesticular cancerurogenital cancer

Identifiers

PMID39858098
PMCPMC11763937

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.